Anti-Cancer Therapeutics: From research to trials to treatment

London, London
Wednesday, 14 May 2014

This is a Euroscicon Small Conference,  an outline of the day can be found at 
www.euroscicon.com/EurosciconMeetingStructure.pdf

This event will be held at The O2,  a large entertainment district on the Greenwich peninsula in South East London, England.

About the Chair:
Ann White
is a Senior Research Fellow within the Cancer Sciences Unit, University of Southampton. Her research is focused upon theoptimisation of anti-cancer therapeutic mAb through the manipulation of mAb structure. Ann received  a PhD in Molecular and CellularBiology from the MRC Clinical Research Centre, Harrow in 1991 then worked for 10 years in the United States on lipoprotein metabolism. After a career break with her young children Ann joined Professor Martin Glennie’s group in 2005 and is part of a programme for thediscovery and optimisation of novel  anti-cancer therapeutic mAb.

About the Speakers:
Sophia N. Karagiannis
 is a translational cancer immunologist specialising in antibody therapies for melanoma, ovarian and breast carcinomas. She received BA and MS degrees at Rutgers University, USA, having received scholarship awards and a teaching assistantship (1987, 1991), and a PhD at King’s College London in Biochemistry under SERC and SmithKline Beecham-funded scholarships (1995). She subsequently developed immunotherapeutic strategies for cancer and inflammatory diseases in academic and biotechnology environments in London and Cambridge as a postdoctoral associate and scientific investigator. She was appointed as NIHR Senior Research Fellow in 2007 and presently leads her own research group as Head of Cancer Antibody Discovery and Immunotherapy at King’s College London, focused on dissecting humoral immunity in cancer and leading research into tumour-targeting mechanisms of IgE antibodies and Th2 responses in cancer. Sophia co-founded the International Task Force on AllergoOncology and has pioneered IgE therapeutics for solid tumours. Her research and development initiative on the first IgE class antibody for cancer therapy is conducted in close collaboration with clinical and academic groups at King's College London and the CR-UK Drug Development Office.

Tracy Robson obtained her PhD in Molecular Radiation Science from Imperial College, London. Her first academic post was as Lecturer in Radiation Science at the University of Ulster in 1997 and she then moved to the School of Pharmacy, Queen's University of Belfast in 2004 to take up the post of Reader in Molecular Pharmacology, within the newly established, Experimental Therapeutics research cluster. She was promoted to Professor in Experimental Therapeutics in Oct 2010. Her main research focus is the development of novel approaches for sensitizing tumours to both radio and chemotherapy. She has published widely, holds several patents on both therapeutic and diagnostic approaches in the cancer area and has given numerous invited conference presentations. She has obtained significant research grant income from industry, BBSRC, MRC, Cancer Research UK, Breast Cancer Campaign, Prostate Cancer Charity, Prostate Cancer Research Foundation and Action Cancer. She is a Fellow of the Society of Biology and has held positions such as Secretary for the Association for Radiation Research, UK, a member of the scientific committee for Action Cancer, NI, and a Council Member of the Irish Association for Cancer Research. She is currently secretary for the Irish Radiation Research Society and is on the Cancer and Radiation Biology scientific committee for the British Institute of Radiobiology.

Xiaoyan Jiang is a Senior Scientist in the Terry Fox Laboratory of the BC Cancer Agency and an Associate Professor in the Department of Medical Genetics at the University of British Columbia in Vancouver, Canada.  She is an expert in basic and translational research of molecular properties of leukemic stem cells that contribute to the development of leukemia and drug resistance and has pioneered efforts to the development of new therapeutic approaches to directly target these critical cells.  She has been invited to present at many international conferences and has organized and/or chaired a number of conference sessions. She has published numerous peers-reviewed publications, has been on the Editorial Board of 18 reputed journals and is the Editor-in-Chief of the World Journal of Hematology.

Mark Guthridge
is an NH&MRC Senior Research Fellow and heads the Leukemia Research Laboratory at the Australian Centre for Blood Diseases (ACBD), Monash University, Melbourne, Australia. Since 2000, his lab has received continual funding from International (NIH, AICR), National (NH&MRC, LFA) and State agencies (Cancer Council of SA) and his work has been published in leading journals including Cell, Molecular Cell, Cell Stem Cell, PLOS Biol and EMBO J. Dr. Guthridge regularly serves on the editorial boards of international peer-reviewed journals, national grant review panels and scientific organizing committees for international cancer conferences.

 

Contact Details

Payment Instructions

  • For enquiries regarding payment email:  accounts@euroscicon.com

    You can pay by - Credit card, Cheque, Purchase Order or Bank transfer.
    Payment must be received prior to the meeting

    Credit card
    You can pay during your online registration using your credit card. The information taken will be by secure server and we use Worldpay and PayPal for our credit card transactions. We always prefer debit cards for transactions, but can also take credit cards and American Express. Using this mode of payment you can guarantee that your fee has reached us prior to the conference and you will be listed as registered

    Cheque Payment
    Cheques should be made payable to Euroscicon and mailed (together with a print out of the invoice which will be available at the end of the registration process).  After registration you will be emailed details of where to send your cheque.

    Purchase Order

    Please input your Purchase Order number in the box provided once you have selected your mode of payment and an invoice will be sent to you accordingly

    Bank transfer
    Clients organizing bank transfers from non-UK banks will need to pay an additional administration fee of £15.00. Please ensure that you add this fee onto your payment to ensure successful registration.  
    After registration you will be emailed details of where transfer your money.

        Linked in   
An event from European Scientific Conferences - Euroscicon "Specialising in communicating cutting edge technology & methodology in the Life Sciences"

EuroSciCon Ltd. Registered in England and Wales, Company number: 4326921, Trading Address:  Euroscicon Ltd, Highstone House, 165 High Street, Barnet, Herts. EN5 5SU, UK.  Registered Office: 47 High Street, Barnet, Herts, EN5 5UW, UK 


© 2017
Quick, easy and affordable online event registration and event management software for all event sizes.